GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuidelOrtho Corp (LTS:0A55) » Definitions » E10

QuidelOrtho (LTS:0A55) E10 : $2.79 (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is QuidelOrtho E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

QuidelOrtho's adjusted earnings per share data for the three months ended in Dec. 2024 was $-2.280. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $2.79 for the trailing ten years ended in Dec. 2024.

During the past 12 months, QuidelOrtho's average E10 Growth Rate was -50.90% per year. During the past 3 years, the average E10 Growth Rate was -11.40% per year. During the past 5 years, the average E10 Growth Rate was 52.70% per year. During the past 10 years, the average E10 Growth Rate was 49.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of QuidelOrtho was 179.40% per year. The lowest was -27.30% per year. And the median was 16.70% per year.

As of today (2025-03-03), QuidelOrtho's current stock price is $43.50. QuidelOrtho's E10 for the quarter that ended in Dec. 2024 was $2.79. QuidelOrtho's Shiller PE Ratio of today is 15.59.

During the past 13 years, the highest Shiller PE Ratio of QuidelOrtho was 597.30. The lowest was 7.40. And the median was 68.55.


QuidelOrtho E10 Historical Data

The historical data trend for QuidelOrtho's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuidelOrtho E10 Chart

QuidelOrtho Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 4.00 5.45 5.70 2.79

QuidelOrtho Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.70 3.24 3.00 3.03 2.79

Competitive Comparison of QuidelOrtho's E10

For the Medical Devices subindustry, QuidelOrtho's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QuidelOrtho's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuidelOrtho's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where QuidelOrtho's Shiller PE Ratio falls into.



QuidelOrtho E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, QuidelOrtho's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-2.28/133.1571*133.1571
=-2.280

Current CPI (Dec. 2024) = 133.1571.

QuidelOrtho Quarterly Data

per share eps CPI Adj_EPS
201503 0.110 99.621 0.147
201506 -0.260 100.684 -0.344
201509 -0.020 100.392 -0.027
201512 -0.010 99.792 -0.013
201603 -0.110 100.470 -0.146
201606 -0.240 101.688 -0.314
201609 -0.020 101.861 -0.026
201612 -0.060 101.863 -0.078
201703 0.420 102.862 0.544
201706 -0.350 103.349 -0.451
201709 -0.160 104.136 -0.205
201712 -0.150 104.011 -0.192
201803 0.860 105.290 1.088
201806 -0.080 106.317 -0.100
201809 0.270 106.507 0.338
201812 0.780 105.998 0.980
201903 0.600 107.251 0.745
201906 0.030 108.070 0.037
201909 0.380 108.329 0.467
201912 0.710 108.420 0.872
202003 0.930 108.902 1.137
202006 1.550 108.767 1.898
202009 5.330 109.815 6.463
202012 10.780 109.897 13.062
202103 4.090 111.754 4.873
202106 0.450 114.631 0.523
202109 5.080 115.734 5.845
202112 6.850 117.630 7.754
202203 11.310 121.301 12.415
202206 0.360 125.017 0.383
202209 0.280 125.227 0.298
202212 0.450 125.222 0.479
202303 0.730 127.348 0.763
202306 -0.800 128.729 -0.828
202309 -0.190 129.860 -0.195
202312 0.100 129.419 0.103
202403 -25.500 131.776 -25.767
202406 -2.200 132.554 -2.210
202409 -0.300 133.029 -0.300
202412 -2.280 133.157 -2.280

Add all the adjusted EPS together and divide 10 will get our e10.


QuidelOrtho  (LTS:0A55) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

QuidelOrtho's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=43.50/2.79
=15.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of QuidelOrtho was 597.30. The lowest was 7.40. And the median was 68.55.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


QuidelOrtho E10 Related Terms

Thank you for viewing the detailed overview of QuidelOrtho's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


QuidelOrtho Business Description

Traded in Other Exchanges
Address
9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

QuidelOrtho Headlines

No Headlines